End-of-day quote
Taiwan S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
156.5
TWD
|
+0.32%
|
|
+0.97%
|
+0.32%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
26,526
|
24,191
|
23,702
|
24,887
|
23,109
|
23,183
|
-
|
Enterprise Value (EV)
1 |
25,629
|
23,270
|
20,277
|
20,097
|
18,362
|
18,446
|
18,329
|
P/E ratio
|
20.2
x
|
19.1
x
|
18.3
x
|
17.2
x
|
16
x
|
14.8
x
|
14.6
x
|
Yield
|
3.33%
|
3.61%
|
3.81%
|
4.11%
|
3.91%
|
4.56%
|
4.72%
|
Capitalization / Revenue
|
2.87
x
|
2.64
x
|
2.42
x
|
2.4
x
|
2.17
x
|
2.01
x
|
1.92
x
|
EV / Revenue
|
2.77
x
|
2.54
x
|
2.07
x
|
1.93
x
|
1.73
x
|
1.6
x
|
1.52
x
|
EV / EBITDA
|
9.66
x
|
8.56
x
|
7.4
x
|
6.7
x
|
6.21
x
|
5.84
x
|
5.49
x
|
EV / FCF
|
16.6
x
|
15.5
x
|
8.94
x
|
8.03
x
|
9.5
x
|
11.9
x
|
10.5
x
|
FCF Yield
|
6.01%
|
6.47%
|
11.2%
|
12.5%
|
10.5%
|
8.38%
|
9.54%
|
Price to Book
|
4.3
x
|
3.65
x
|
2.63
x
|
2.6
x
|
2.32
x
|
2.2
x
|
1.85
x
|
Nbr of stocks (in thousands)
|
136,032
|
136,286
|
148,137
|
148,137
|
148,137
|
148,137
|
-
|
Reference price
2 |
195.0
|
177.5
|
160.0
|
168.0
|
156.0
|
156.5
|
156.5
|
Announcement Date
|
24/02/20
|
26/02/21
|
24/02/22
|
23/02/23
|
27/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
9,239
|
9,168
|
9,798
|
10,391
|
10,635
|
11,529
|
12,070
|
EBITDA
1 |
2,654
|
2,720
|
2,739
|
3,001
|
2,956
|
3,159
|
3,340
|
EBIT
1 |
2,335
|
2,305
|
2,312
|
2,552
|
2,497
|
2,721
|
2,770
|
Operating Margin
|
25.27%
|
25.14%
|
23.59%
|
24.56%
|
23.47%
|
23.6%
|
22.95%
|
Earnings before Tax (EBT)
1 |
2,440
|
2,378
|
2,415
|
2,688
|
2,661
|
2,898
|
3,023
|
Net income
1 |
1,309
|
1,272
|
1,300
|
1,457
|
1,453
|
1,599
|
1,670
|
Net margin
|
14.17%
|
13.87%
|
13.27%
|
14.02%
|
13.66%
|
13.87%
|
13.84%
|
EPS
2 |
9.630
|
9.290
|
8.760
|
9.780
|
9.740
|
10.57
|
10.74
|
Free Cash Flow
1 |
1,541
|
1,505
|
2,267
|
2,504
|
1,932
|
1,545
|
1,749
|
FCF margin
|
16.68%
|
16.42%
|
23.14%
|
24.09%
|
18.17%
|
13.4%
|
14.49%
|
FCF Conversion (EBITDA)
|
58.07%
|
55.35%
|
82.77%
|
83.42%
|
65.36%
|
48.91%
|
52.36%
|
FCF Conversion (Net income)
|
117.73%
|
118.35%
|
174.33%
|
171.83%
|
133.01%
|
96.64%
|
104.73%
|
Dividend per Share
2 |
6.500
|
6.400
|
6.100
|
6.900
|
6.100
|
7.143
|
7.385
|
Announcement Date
|
24/02/20
|
26/02/21
|
24/02/22
|
23/02/23
|
27/02/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
2,404
|
2,919
|
2,053
|
2,722
|
2,492
|
3,124
|
2,220
|
2,665
|
2,551
|
3,200
|
2,384
|
2,882
|
2,813
|
3,554
|
EBITDA
|
684.7
|
875.6
|
-
|
780.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
578
|
767.7
|
421.8
|
668.4
|
639
|
822.5
|
478.2
|
562.1
|
634
|
822.3
|
501.3
|
643
|
683.7
|
944
|
Operating Margin
|
24.05%
|
26.3%
|
20.55%
|
24.55%
|
25.64%
|
26.33%
|
21.54%
|
21.09%
|
24.86%
|
25.69%
|
21.03%
|
22.31%
|
24.3%
|
26.56%
|
Earnings before Tax (EBT)
1 |
605.7
|
802
|
447.8
|
701.5
|
672.1
|
866.4
|
510.6
|
606.4
|
681.4
|
862.2
|
529.7
|
675
|
717.3
|
976
|
Net income
1 |
302
|
440
|
235.7
|
385
|
364.8
|
471.5
|
279.8
|
337.9
|
366.7
|
468.3
|
284.7
|
374.3
|
392.7
|
547
|
Net margin
|
12.57%
|
15.08%
|
11.48%
|
14.14%
|
14.64%
|
15.09%
|
12.6%
|
12.68%
|
14.38%
|
14.63%
|
11.94%
|
12.99%
|
13.96%
|
15.39%
|
EPS
2 |
2.030
|
2.950
|
1.580
|
2.590
|
2.450
|
3.160
|
1.880
|
2.280
|
2.470
|
3.130
|
1.923
|
2.523
|
2.650
|
3.693
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/11/21
|
24/02/22
|
12/05/22
|
11/08/22
|
08/11/22
|
23/02/23
|
10/05/23
|
10/08/23
|
10/11/23
|
27/02/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
897
|
921
|
3,425
|
4,790
|
4,748
|
4,737
|
4,855
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,541
|
1,505
|
2,267
|
2,504
|
1,932
|
1,545
|
1,749
|
ROE (net income / shareholders' equity)
|
22%
|
19.9%
|
16.7%
|
15.7%
|
14.9%
|
14.1%
|
14.6%
|
ROA (Net income/ Total Assets)
|
11.9%
|
10.4%
|
9.57%
|
10%
|
9.51%
|
13.5%
|
16.7%
|
Assets
1 |
11,004
|
12,231
|
13,582
|
14,557
|
15,282
|
11,886
|
10,000
|
Book Value Per Share
2 |
45.40
|
48.60
|
60.90
|
64.60
|
67.40
|
71.10
|
84.40
|
Cash Flow per Share
2 |
15.90
|
19.90
|
17.10
|
20.10
|
17.00
|
14.20
|
13.20
|
Capex
1 |
630
|
1,214
|
275
|
487
|
587
|
553
|
563
|
Capex / Sales
|
6.82%
|
13.24%
|
2.81%
|
4.68%
|
5.52%
|
4.8%
|
4.66%
|
Announcement Date
|
24/02/20
|
26/02/21
|
24/02/22
|
23/02/23
|
27/02/24
|
-
|
-
|
Last Close Price
156.5
TWD Average target price
172.8
TWD Spread / Average Target +10.38% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.32% | 711M | | +8.20% | 7.78B | | +0.34% | 7.38B | | +10.20% | 6.52B | | -8.10% | 3.67B | | -13.13% | 3.44B | | -14.57% | 1.17B | | +8.34% | 934M | | -42.27% | 879M | | -18.90% | 836M |
Special Foods & Wellbeing Products
|